Connect with us


Neptune Acquires Hemp Extraction Facility SugarLeaf Labs in a Multimillion Deal to Enter CBD Field

Kim Denise



Neptune Acquires Hemp Extraction Facility SugarLeaf Labs in a Multimillion Deal to Enter CBD Field
- Ad -

After the acquisition of Sugarleaf Labs (a North Carolina hemp products producer), Neptune Wellness Solutions has moved into the United States’ CBD field.

This deal was announced earlier this week and is valued at $18 million on an upfront basis. Over time, it could be as much as $150.

Neptune Wellness Solutions said that SugarLeaf comes with what Neptune refers to “cutting-edge cold ethanol” processing technology housed at a Conover facility. The facility has an up to 1.5 million kg of raw hemp theoretical capacity yearly. The company claims that SugarLeaf has excellent relationships with American growers who have the right experiences with the plant and cultivation licenses.

Neptune was one of the first to introduce krill oil for dietary supplementation. After selling the business to Aker BioMarine, it pivoted its Sherbrooke processing facility to CBD products. With the regulatory complexities of the hemp trade though, the company cannot export anything from the plant to the U.S.

Tobacco Belt Might Eventually Become Hemp Belt

According to Jim Hamilton, Neptune’s CEO, the Southeastern US is a place to be. The company loves the fact that they are in a tobacco country, and they have a view that the tobacco belt could be the place with the ideal position for future business. Hamilton said that there is a big Agri-infrastructure there that will support their business going forward.

Other than the location and the strategic agricultural partnerships, the CEO believes that SugarLeaf had all its i’s dotted, and t’s crossed when it came to regulatory and scientific concerns. Hamilton said that Neptune had toured operations of several potential partners, and had seen companies which run the gamut from naïve to sophisticated. He noted that the hemp industry has players who are new to the manufacture of ingestible products, and the search was hence frustrating since some companies do not understand what is required to run a fully compliant and successful production facility within the industry.

Knowledgeable Partners Will Be of Great Help

According to Hamilton, Extraction facilities with processes in place will have a significant impact on the CBD/hemp industry. Also, companies at a great level in the industry will not have the patience to educate potential partners on basic dietary supplement parameters and the manufacture of food ingredients.

As of now, aspects of CBD/hemp regulation are still in turmoil. Dr. Scott Gottileb MD, the former commissioner for US Food and Drug Administration, had heard suggestions from lawmakers who intend to find a legal way for these products coming to the market, and a public meeting is set on May 31 by the FDA. This will be a significant step to bringing some clarity to the tricky hemp situation.

Kim or ‘KimD’ is an experienced, astute full-time writer with a Bachelor’s Degree in Literature. While her professional path is in Commercial Real Estate as an Accredited Buyer’s Representative and the financial industry, she loves to elaborate exclusively about CBD health and wellness information here at COR and will be around for a long time to come.

Continue Reading

Ultimate CBD Guide


ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email

Copyright © 2020 | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.